BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4206731)

  • 21. Pharmacokinetics and bronchodilatory effect of proxyphylline and theophylline.
    Rasmussen FV; Waldorff S; Madsen L
    Eur J Respir Dis; 1984 Jan; 65(1):20-7. PubMed ID: 6705854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Theophylline levels in the serum after intravenous injection of thephyllamine].
    Horwitz N; Jürgensen HJ; Nielsen HR
    Ugeskr Laeger; 1979 Dec; 141(50):3443-4. PubMed ID: 545776
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.
    Jenne JW; Wyze MS; Rood FS; MacDonald FM
    Clin Pharmacol Ther; 1972; 13(3):349-60. PubMed ID: 5026376
    [No Abstract]   [Full Text] [Related]  

  • 24. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma theophylline level and effect on lung function after oral and rectal administration of aminophylline.
    Lamont H; Moerman E; Bogaert M; Van Der Straeten M; Pauwels R
    Eur J Clin Pharmacol; 1979 Jul; 15(6):401-6. PubMed ID: 499288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tablets.
    Sansom LN; Milne RW; Cooper D
    Eur J Clin Pharmacol; 1979; 16(6):417-21. PubMed ID: 583332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biopharmaceutical evaluation of aminophylline suppositories. I. Pharmacological parameters of theophylline from aminophylline suppositories with normal and prolonged time of total deformation].
    Masiakowski J; Cieszyński T; Dyderski S; Perz A
    Acta Pol Pharm; 1984; 41(1):99-104. PubMed ID: 6496143
    [No Abstract]   [Full Text] [Related]  

  • 28. [Disposition of theophylline in healthy non-smoker volunteers after a single oral dose of aminophylline].
    Prat G; Gazitúa R; Arriagada D; Montero J; Serrat H; Ruiz M; Leiva P
    Rev Med Chil; 1986 Dec; 114(12):1164-7. PubMed ID: 3602698
    [No Abstract]   [Full Text] [Related]  

  • 29. Theophylline elimination in the pregnant and fetal rabbit.
    Brashear RE; Veng-Pedersen P; Rhodes ML; Smith CN
    J Lab Clin Med; 1982 Jul; 100(1):15-25. PubMed ID: 7086267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative plasma pharmacokinetics of theophylline and ethylenediamine after the administration of aminophylline to man.
    Cotgreave IA; Caldwell J
    J Pharm Pharmacol; 1983 Jun; 35(6):378-82. PubMed ID: 6135777
    [No Abstract]   [Full Text] [Related]  

  • 31. Factors influencing the dose of oral aminophylline [proceedings].
    Eppel ML; Mackay A; Oliver JS; Ramsay LE
    Br J Clin Pharmacol; 1979 Oct; 8(4):384P. PubMed ID: 508521
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative bioavailability of two uncoated aminophylline tablets.
    Kwok F; Kradjan WA; Lakshminarayan S; Delaney C
    Am J Hosp Pharm; 1980 Dec; 37(12):1618, 1620. PubMed ID: 7446536
    [No Abstract]   [Full Text] [Related]  

  • 33. [Tolerance and effect of short-term theophylline infusions].
    Schmidt M
    Pneumologie; 1993 Jan; 47(1):30-5. PubMed ID: 8437976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetic research on theophylline].
    Tsoĭ AN; Gneushev ET; Bogovskiĭ BP; Kaz'mina EM; Abrosimov AG
    Farmakol Toksikol; 1987; 50(1):89-91. PubMed ID: 3556561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serum levels of theophylline and rate of administration by intravenous route].
    Cukier A; Santos SR; Terra Filho M; Fiss E; Silva GM; Saad E; Romeiro Neto M; Vargas FS
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(3):115-7. PubMed ID: 3454044
    [No Abstract]   [Full Text] [Related]  

  • 36. [The pharmacokinetic characteristics of theophylline in patients with chronic nonspecific intestinal diseases in relation to its routes of administration into the gastrointestinal tract].
    Kukes VG; Fazylov AV; Kirkin BV; Kurapov AP; Blinov IL
    Ter Arkh; 1993; 65(2):52-4. PubMed ID: 9133013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
    Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood theophylline concentration following the oral administration of theophylline ethylenediamine and theophylline isopropanolamine.
    VIVINO AE
    J Am Pharm Assoc Am Pharm Assoc; 1954 Apr; 43(4):234-5. PubMed ID: 13151986
    [No Abstract]   [Full Text] [Related]  

  • 39. Kinetics of intravenous theophylline.
    Chrzanowski FA; Niebergall PJ; Mayock RL; Taubin JM; Sugita ET
    Clin Pharmacol Ther; 1977 Aug; 22(2):188-95. PubMed ID: 884920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A re-evaluation of parenteral aminophylline.
    Nicholson DP; Chick TW
    Am Rev Respir Dis; 1973 Aug; 108(2):241-7. PubMed ID: 4720690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.